Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
X-linked lymphoproliferative disease (XLP) is a primary immunodeficiency caused by mutations in SH2D1A which encodes SAP. SAP functions in signalling pathways elicited by the SLAM family of leukocyte receptors. A defining feature of XLP is exquisite sensitivity to infection with EBV, a B-lymphotropi...
Guardado en:
Autores principales: | Umaimainthan Palendira, Carol Low, Anna Chan, Andrew D Hislop, Edwin Ho, Tri Giang Phan, Elissa Deenick, Matthew C Cook, D Sean Riminton, Sharon Choo, Richard Loh, Frank Alvaro, Claire Booth, H Bobby Gaspar, Alessandro Moretta, Rajiv Khanna, Alan B Rickinson, Stuart G Tangye |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f8dac67c92b469bb76a09f459caef5b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
EBV Positive Aggressive NK-Cell Leukemia
por: Ankitha Hebbar, et al.
Publicado: (2021) -
Complete response to PD-1 blockade following EBV-specific T-cell therapy in metastatic nasopharyngeal carcinoma
por: Corey Smith, et al.
Publicado: (2021) -
Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells.
por: J Luis Espinoza, et al.
Publicado: (2012) -
Methodological bases of differential detection of the EBV1/EBV2 and HHV6A/HHV6B
por: M. Popkova, et al.
Publicado: (2019) -
Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice.
por: Olga Antsiferova, et al.
Publicado: (2014)